Medical News

RSS

Date set for Ryan Phua Memorial Kids' Ride, Burlingame Criterium

The 7th annual Ryan Phua Memorial Kids' Ride, featuring more than 700 kids of all ages, will once again provide one of the key highlights at the 24th annual Burlingame Criterium, set for Sunday, June 27, 2010. The race activities will fill the streets, restaurants and shops of downtown Burlingame with thousands of competitive cyclists, children, volunteers and spectators. Adding to the excitement of Ryan's Ride, the day's multiple races will culminate in a Men's pro event and a separate Women's pro event.

19 Jun 2010

Report examines G8's $22B food security pledge, highlights need for funding delivery

A report from the anti-poverty group ActionAid finds that less than one-third of the $22 billion that was pledged to improve food security during a 2009 G8 meeting in L'Aquila, Italy, is from new funding sources, the U.K. Press Association reports (6/18).

19 Jun 2010

Medicare begins 21% payment cuts to physicians

Today, Medicare begins processing physician payments with the drastic 21 percent cut that Congress failed to stop, and now seniors and physicians are paying the price of Congress' Medicare mismanagement.

19 Jun 2010

Oncolytics Biotech issued patent that covers methods for treating cell proliferative disorders

Oncolytics Biotech Inc. today announced that it has been granted its 35th U.S. Patent, # 7,731,951 entitled "Viruses for the Treatment of Cellular Proliferative Disorders." The patent claims cover methods for treating cell proliferative disorders by administering modified vaccinia virus to proliferating cells having an activated Ras-pathway.

19 Jun 2010

TFAH recognizes steps taken by Obama Administration on Prevention and Public Health Fund

Trust for America's Health today recognized the crucial first steps taken by the Obama Administration to allocate the recent health reform Act's Prevention and Public Health Fund, but acknowledged that in year one, half of the Fund's dollars were redirected outside the scope of its Congressional intent.

19 Jun 2010

BioTime announces warrant discount offer

BioTime, Inc. announced today that it is commencing a warrant discount offer under which it will permit holders of its common share purchase warrants expiring October 31, 2010 to exercise their warrants at a discounted price of $1.818 per share, which represents a discount of $0.182 from the regular warrant exercise price of $2.00 per share.

19 Jun 2010

AdnaGen signs option agreement to license specific antibodies to KellBenx

AdnaGen AG, a subsidiary of OncoVista Innovative Therapies, Inc., a high-growth global biotech company developing proprietary, leading-edge early detection and drug technologies to enable safe, targeted personal cancer treatments, today announced that it has entered into an option agreement to license specific antibodies to KellBenx Inc., a New York-based private biotech firm.

19 Jun 2010

Conscious sedation for glioma resection shortens hospital stay

The recovery time and cost of brain-tumor surgery might both be reduced if surgery is performed while patients are awake during part of the procedure, according to a new study conducted at The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

19 Jun 2010

Preclinical study shows treatment with DAS181 inhibits infection with multiple HPIV strains

NexBio, Inc. announced today the publication of a "Major Article" in the Journal of Infectious Diseases of a preclinical study showing that treatment with DAS181 (Fludase) inhibits infection with multiple human parainfluenza virus strains. DAS181 is a broad spectrum host-targeted investigational drug candidate for treatment and prevention of Influenza-Like Illness.

19 Jun 2010

Health Robotics announces new Canadian marketing contracts for i.v.STATION, i.v.SOFT

Health Robotics announced that its joint-venture Health Robotics Canada Inc. (HRCI), a leading Canadian Pharmaceutical Company, and a well-established Quebec-based Medical Device Technology company have all recently signed marketing agreements in order to expand into Canada the market presence of i.v.STATION and i.v.SOFT, revolutionary technologies that provide automated sterile compounding of intravenous medications and parenteral nutrition to hospitals.

19 Jun 2010

ARS research physiologist develops preliminary model that predicts individual's vitamin D requirements

Your skin tone and the amount of sunshine you receive--in addition to what foods you eat--all can influence the amount of vitamin D that your body has on hand for optimum health. In a preliminary and apparently first-of-its-kind study, Agricultural Research Service research physiologist Charles B. Stephensen and colleagues have developed a preliminary model that predicts an individual's vitamin D requirements.

19 Jun 2010

Bracco release confirms Positron's market growth prediction of cardiac PET

Positron Corporation, a leader as a molecular imaging and solutions company specializing in the field of Nuclear Cardiology, cites an article posted on AuntMinnie.com, the largest community website for medical imaging professionals, relating to the growth in cardiac PET.

19 Jun 2010

ThermoGenesis to seek stockholder approval for reverse stock split

ThermoGenesis Corp., a leading supplier of innovative products and services that process and store adult stem cells, said today it will seek stockholder approval of an authorization enabling its Board of Directors in its discretion to affect a reverse stock split in the range of one-for-three to one-for-five shares of common stock in the near future, if required to maintain NASDAQ listing. The authorization will be voted upon during a special meeting of stockholders to be held on Monday, August 9th.

19 Jun 2010

PSC receives accreditation under UL's Data Acceptance Program to serve lighting and medical device industries

Following the successful completion of a rigorous audit by Underwriters Laboratories (Northbrook, IL) this month, Product Safety Consulting, Inc. (Bensenville, IL) announced today that they have received formal accreditation under UL's Data Acceptance Program to better serve two vibrant and growing sectors of the American economy: lighting products and medical devices.

19 Jun 2010

Lawyer chronicles history, evolution of advance directives

When first developed in the 1970s, advance directives focused on providing specific legal instructions, such as a patient's wishes to withdraw or withhold life-sustaining treatment in cases of terminal illness or incapacity. The documents helped physicians avoid legal problems associated with fulfilling the patient's wishes.

19 Jun 2010

Investigators discover new way to harness thrombin's anti-blood clotting properties

In research led by a Saint Louis University investigator, molecular biologists have discovered a way to harness the enzyme thrombin's anti-blood clotting properties. The finding opens the door to new medications that will treat diseases related to thrombosis, the presence of blood clots in blood vessels, which is responsible for nearly a third of all deaths in the U.S.

19 Jun 2010

Group Net donates $1000 to Horizon Relief to help individuals affected by oil spill

Group Net LLC, a health care service company specializing in prescription medication and pharmacy technology solutions, donated $1000 to Horizon Relief, an organization that provides financial relief to those affected by the oil spill.

19 Jun 2010

Phase III clinical trial data of Cayston versus TIS in CF patients with P. aeruginosa presented at ECFC 2010

Gilead Sciences, Inc. today announced that its head-to-head Phase III clinical trial of Cayston (aztreonam for inhalation solution) versus tobramycin inhalation solution in cystic fibrosis patients with Pseudomonas aeruginosa achieved one of its co-primary endpoints of non-inferiority for mean percent change in forced expiratory volume in one second (FEV1) percent predicted after 28 days of treatment.

19 Jun 2010

Childrens Hospital Los Angeles awarded $2.5M NIH grant to study risk of osteoporosis in spina bifida children

Tishya Wren, PhD, of The Saban Research Institute at Childrens Hospital Los Angeles, has received a $2.5 million grant from the National Institutes of Health - National Institute of Child Health and Human Development to study bone development in children with myelomeningocele, the most severe type of spina bifida .

19 Jun 2010

esperanza Magazine's feature article Marriage Matters wins 2010 MHA Media Award

esperanza Magazine's feature article "Marriage Matters" has won a Mental Health America 2010 Media Award in the national magazine category. esperanza Magazine was among 15 media outlets honored by MHA at an awards luncheon held June 12 during the advocacy organization's 2010 annual conference in Washington, DC. The awards honor excellence in reporting and portrayals of mental health issues.

19 Jun 2010

Medical News

Date set for Ryan Phua Memorial Kids' Ride, Burlingame Criterium

Report examines G8's $22B food security pledge, highlights need for funding delivery

Medicare begins 21% payment cuts to physicians

Oncolytics Biotech issued patent that covers methods for treating cell proliferative disorders

TFAH recognizes steps taken by Obama Administration on Prevention and Public Health Fund

BioTime announces warrant discount offer

AdnaGen signs option agreement to license specific antibodies to KellBenx

Conscious sedation for glioma resection shortens hospital stay

Preclinical study shows treatment with DAS181 inhibits infection with multiple HPIV strains

Health Robotics announces new Canadian marketing contracts for i.v.STATION, i.v.SOFT

ARS research physiologist develops preliminary model that predicts individual's vitamin D requirements

Bracco release confirms Positron's market growth prediction of cardiac PET

ThermoGenesis to seek stockholder approval for reverse stock split

PSC receives accreditation under UL's Data Acceptance Program to serve lighting and medical device industries

Lawyer chronicles history, evolution of advance directives

Investigators discover new way to harness thrombin's anti-blood clotting properties

Group Net donates $1000 to Horizon Relief to help individuals affected by oil spill

Phase III clinical trial data of Cayston versus TIS in CF patients with P. aeruginosa presented at ECFC 2010

Childrens Hospital Los Angeles awarded $2.5M NIH grant to study risk of osteoporosis in spina bifida children

esperanza Magazine's feature article Marriage Matters wins 2010 MHA Media Award

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News